Metabolic dysfunction in patients with 
NAFLD, cirrhosis
INSULIN RESISTANCE, CIRRHOSIS
Glucose, C‐peptide, and glucagon concentrations were as expected stable over the 120 min study period in participants allocated to fasting. Patients with cirrhosis had numerical highest glucose levels. Glucose concentrations were similar in patients with NAFLD and healthy controls, while C‐peptide concentrations were 2‐fold increased in NAFLD compared to healthy and similar to patients with cirrhosis. (Figure Patients with NAFLD and cirrhosis have glucagon and insulin resistance during fasting and in a postprandial state. (a) Glucose concentrations in fasting healthy, NAFLD and cirrhosis (Glucagon concentrations were higher in patients with NAFLD and cirrhosis compared to healthy (Figure 